Development

 is Industry Market Manager Biopharma, Pharma EMEA - Brenntag GmbH.

Articles

Biopharmaceutical production faces the challenge of ensuring the quality of raw materials due to a lack of specific guidelines. By implementing effective risk assessment strategies and working with reliable, selected solution providers, biopharmaceutical manufacturers can minimize these challenges and improve product quality.

The Quest for Quality: Challenges and Strategies in Raw Material Selection for Biopharmaceuticals

Feliza Mirasol is the science editor for 

A strategic partnership between LenioBio and Labscoop is aimed at making scalable cell-free protein synthesis technology more accessible across North America.

LenioBio and Labscoop’s Strategic Partnership Aimed at Enhancing Access to Cell-Free Protein Synthesis

Syngene has launched a new protein production platform that offers faster production with lower risk.

Syngene Launches Rapid Protein Synthesis Platform

Twist Bioscience now offers its Express Genes rapid gene synthesis service at its Wilsonville, Ore., manufacturing facility.

Twist Bioscience Launches Gene Synthesis Service

The agreement states that Orbit will implement its bead-based peptide display engine to discover peptide leads specific to targets related to specific tumors.

Orano Med and Orbit Discovery Enter Collaboration for New Novel Targeted Radioligand Therapies 

The collaboration partner for Willow is focused on more sustainable methods to manufacture intermediates and APIs at reduced cost and less waste, in addition to looking for Willow’s expertise in developing and scaling key ingredients.

Willow Biosciences Announces Collaboration with Biopharma Company 

Camena Bioscience has completed $10 million in Series A financing on the back of growing demand for DNA synthesis.

Camena Bioscience Raises $10 Million to Pursue DNA Synthesis Technology

Grant Playter is the Assistant Editor for 

The new excipients manufacturing facility is expected to be completed in 2025.

Croda Pharma Breaks Ground on Excipients Manufacturing Facility

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

When one is using continuous hot-melt extrusion to enhance solubility, process control is essential.

Addressing Poorly Soluble APIs with Continuous Hot-Melt Extrusion

Curia is collaborating with Corning to advance biopharmaceutical continuous-flow development and manufacturing programs.

API Synthesis and Manufacturing, Large Molecule